Randomized Study of Minocycline and Edetic Acid as a Locking Solution for Central Line (Port-A-Cath) in Children with Cancer

Authors:
  • EAEmília Hato de Almeida
    Emília Hato de Almeida
  • RSRegina de Lourdes Simões
    Regina de Lourdes Simões
  • VOViviane Lazzarin C. Ozório
    Viviane Lazzarin C. Ozório
  • BABenaia Cândida Alves
    Benaia Cândida Alves
  • MAMaria Lydia Mello de Andréa
    Maria Lydia Mello de Andréa
  • MBMarcela Santiago Biernat
    Marcela Santiago Biernat
  • JBJoão Carlos Biernat
    João Carlos Biernat

Abstract
Background: Contamination of central catheters is frequent, and biofilm perpetuates infections. Heparin does not protect against infections because it has no antibiotic action. Minocycline and edetic acid (M-EDTA), a potent calcium chelating agent that destroys bacterial and fungal cell membrane and disrupts biofilm, may be an alternative to allow the associated antibiotic to act locally at a high and safe concentration. Methods: Fifty children with cancer and a port-a-cath were followed up: 26 received heparin (group 1) and 24 M-EDTA (group 2). A total of 762 serial prospective blood cultures were obtained, 387 from group 1 and 375 from group 2. Results: In group 1 (heparin), 19 blood cultures were positive, and infection incidence was 73.1% (19/26 ports). In group 2 (M-EDTA), 5 blood cultures were positive, and the incidence rate was 20.8% (5/24 ports). Conclusion: M-EDTA, compared with heparin, prevents and treats catheter infections, and is a promising alternative to decrease sepsis during chemotherapy.

This publication has 41 references indexed in Scilit: